These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 416322)

  • 21. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of fatty acid metabolism by glucagon in man. IV. Effects of a physiologic hormone infusion in normal man.
    Schade DS; Eaton RP
    Diabetes; 1976 Oct; 25(10):978-83. PubMed ID: 976607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man.
    Schade DS; Eaton RP
    J Clin Endocrinol Metab; 1980 Jan; 50(1):131-6. PubMed ID: 7350176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ketotic effects of glucocorticoid and growth hormone in man.
    Schade DS; Eaton RP; Peake GT
    Acta Diabetol Lat; 1980; 17(2):161-9. PubMed ID: 7004043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid regulation of plasma ketone body concentration in insulin devicient man.
    Schade DS; Eaton RP; Standefer J
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1069-79. PubMed ID: 874044
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppressible glucagon secretion in young, ketosis-resistant, type "J" diabetic patients in India.
    Rao RH; Vigg BL; Rao KS
    Diabetes; 1983 Dec; 32(12):1168-71. PubMed ID: 6418596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and hormonal effects of muscular exercise in juvenile type diabetics.
    Berger M; Berchtold P; Cüppers HJ; Drost H; Kley HK; Müller WA; Wiegelmann W; Zimmerman-Telschow H; Gries FA; Krüskemper HL; Zimmermann H
    Diabetologia; 1977 Aug; 13(4):355-65. PubMed ID: 410693
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of glucagon in the regulation of plasma lipids.
    Schade DS; Woodside W; Eaton RP
    Metabolism; 1979 Aug; 28(8):874-86. PubMed ID: 378241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic effects of glycerol administered to diabetic patients.
    Freund G
    Arch Intern Med; 1968 Feb; 121(2):123-9. PubMed ID: 4965864
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
    Ferrari C; Frezzati S; Romussi M; Bertazzoni A; Testori GP; Antonini S; Paracchi A
    Metabolism; 1977 Feb; 26(2):129-39. PubMed ID: 834147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance and diabetic ketoacidosis].
    Alberti KG
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():79-90. PubMed ID: 827649
    [No Abstract]   [Full Text] [Related]  

  • 32. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients.
    Avogaro A; Crepaldi C; Miola M; Maran A; Pengo V; Tiengo A; Del Prato S
    J Endocrinol Invest; 1996 Feb; 19(2):99-105. PubMed ID: 8778173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physiolopathologic aspects of diabetic ketosis and the ketosis of fasting].
    Balasse EO
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():21-33. PubMed ID: 827647
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease.
    Enger SC; Johnsen V; Samuelsen A; Laws EA
    Acta Med Scand; 1977; 201(6):563-6. PubMed ID: 327758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlations between NEFA and ketone bodies in normal and diabetic subjects].
    Odetti P; Diara C; Corsi L; Viviani G; Maiello M; Cordera R; De Micheli A; Prando R
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):146-52. PubMed ID: 7002170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitus.
    Durocher LL; Hinchcliff KW; DiBartola SP; Johnson SE
    J Am Vet Med Assoc; 2008 May; 232(9):1310-20. PubMed ID: 18447775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man.
    Schade DS; Eaton RP
    Diabetes; 1979 Jan; 28(1):5-10. PubMed ID: 759250
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of alanine, glucose and starch ingestion on the ketosis produced by exercise and by starvation.
    Koeslag JH; Noakes TD; Sloan AW
    J Physiol; 1982 Apr; 325():363-76. PubMed ID: 7050344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis.
    Owen OE; Trapp VE; Reichard GA; Mozzoli MA; Smith R; Boden G
    Diabetes; 1980 May; 29(5):365-72. PubMed ID: 6769726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.